Holen Sie sich die Stockscreener-App
13.80
0.29%
-0.04
Enanta Pharmaceuticals Inc Aktie (ENTA) Neueste Nachrichten
What Makes Enanta Pharmaceuticals (ENTA) a New Buy Stock - Yahoo Finance
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Equities Analysts Issue Forecasts for ENTA Q2 Earnings - MarketBeat
Analysts Are Updating Their Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Estimates After Its First-Quarter Results - simplywall.st
The Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) First-Quarter Results Are Out And Analysts Have Published New Forecasts - 富途牛牛
Enanta (ENTA) Announces $150 Million Mixed Securities Shelf Registration - GuruFocus
Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for - PharmiWeb.com
Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the Treatment of Type 2 Immune Diseases, at the 2026 AAAAI Annual Meeting - BioSpace
Enanta Pharma (ENTA): Analyst Reiterates Buy Rating with $20 PT - GuruFocus
HC Wainwright Reaffirms "Buy" Rating for Enanta Pharmaceuticals (NASDAQ:ENTA) - MarketBeat
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025 - BioSpace
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 202 - PharmiWeb.com
Enanta Pharmaceuticals (ENTA) Reports Strong Q1 Revenue and Fina - GuruFocus
Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Enanta Pharmaceuticals (NASDAQ:ENTA) Posts Earnings Results, Beats Estimates By $0.12 EPS - MarketBeat
Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot - KVUE
Enanta Pharmaceuticals: Overview of Fiscal First Quarter Earnings - Bitget
Enanta Pharma Earnings Review: Q1 Summary - Benzinga
The Technical Signals Behind (ENTA) That Institutions Follow - Stock Traders Daily
Earnings Preview For Enanta Pharma - Benzinga
Enanta Pharmaceuticals (ENTA) Projected to Post Quarterly Earnings on Monday - MarketBeat
Rate Hike: Does Enanta Pharmaceuticals Inc have consistent dividend growthPortfolio Performance Report & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Insider Sell: What are Asset Entities Incs technical support levelsMarket Trend Report & High Accuracy Trade Alerts - baoquankhu1.vn
Precision Trading with Enanta Pharmaceuticals Inc. (ENTA) Risk Zones - Stock Traders Daily
Enanta (NASDAQ: ENTA) seeks 1.6M-share boost to 2019 equity plan - Stock Titan
CEO Moves: Why is Enanta Pharmaceuticals Inc stock going up2025 Market WrapUp & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Sentiment Review: What are Enanta Pharmaceuticals Inc.’s technical support levelsDividend Hike & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Guidance Update: Why is SWKH stock going downSwing Trade & Verified Short-Term Plans - baoquankhu1.vn
Enanta Pharmaceuticals to Present at the Wells Fargo Securities 2013 Healthcare Conference - AOL.com
Why Enanta Pharmaceuticals Inc. stock appeals to analystsJobs Report & Free Long-Term Investment Growth Plans - bollywoodhelpline.com
Technical Reactions to ENTA Trends in Macro Strategies - Stock Traders Daily
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
JPM26: Enanta outlines strategy to lead in RSV therapeutics - Yahoo Finance
Chipmakers Recap: Is Enanta Pharmaceuticals Inc stock affected by interest rate hikesPortfolio Update Report & Free Technical Pattern Based Buy Signals - Bộ Nội Vụ
Income Plays: What makes Enanta Pharmaceuticals Inc. stock attractive to growth fundsJuly 2025 Market Mood & Growth Focused Entry Point Reports - Bộ Nội Vụ
Downgrade Watch: Why is Enanta Pharmaceuticals Inc stock going upJuly 2025 Summary & Trade Opportunity Analysis - baoquankhu1.vn
Is Enanta Pharmaceuticals Inc. stock trading at a premium valuationJuly 2025 Trade Ideas & Reliable Trade Execution Plans - ulpravda.ru
Will Enanta Pharmaceuticals Inc. stock gain from strong economyAnalyst Downgrade & Safe Swing Trade Setups - Улправда
Enanta Pharmaceuticals, Inc.Common Stock (NQ: ENTA - FinancialContent
What makes Enanta Pharmaceuticals Inc. stock attractive to growth fundsTrade Execution Strategies & Our Experts Decode Market Noise for You - bollywoodhelpline.com
Enanta advances RSV and immunology pipeline with key milestones ahead By Investing.com - Investing.com Nigeria
Enanta Pharmaceuticals (NASDAQ:ENTA) Receives "Buy" Rating from HC Wainwright - MarketBeat
Enanta Pharma (ENTA) Receives Buy Rating, Price Target Maintained | ENTA Stock News - GuruFocus
Baird reiterates Outperform rating on Enanta Pharmaceuticals stock By Investing.com - Investing.com Canada
Will Enanta Pharmaceuticals Inc. stock benefit from automationQuarterly Portfolio Summary & Daily Oversold Bounce Ideas - Улправда
Is Enanta Pharmaceuticals Inc. stock a safe haven assetWeekly Trend Report & Weekly Stock Breakout Alerts - ulpravda.ru
What valuation multiples suggest for Enanta Pharmaceuticals Inc. stock2025 Breakouts & Breakdowns & Fast Moving Market Watchlists - Улправда
Is Enanta Pharmaceuticals Inc. stock a bargain at current levelsJuly 2025 Rallies & Risk Controlled Daily Plans - Улправда
Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook - PharmiWeb.com
Enanta advances RSV and immunology pipeline with key milestones ahead - Investing.com
Trading the Move, Not the Narrative: (ENTA) Edition - Stock Traders Daily
Enanta Pharma (ENTA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference - BioSpace
Enanta Pharmaceuticals Insider Ups Holding During Year - Yahoo Finance
0.65%
0.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):